Full-Time

Field Service Engineer

Posted on 5/9/2026

Gator Bio

Gator Bio

11-50 employees

Biomolecular interaction analysis via BLI sensors

Compensation Overview

$90k - $120k/yr

Boston, MA, USA

In Person

Category
Lab & Research (2)
,
Requirements
  • BS in bioengineering, engineering, optical engineering, or related field
  • Minimum three years of hands-on experience of instrumentation service
  • Ability to troubleshoot, test, repair and service technical and mechanical equipment
  • Ability to adapt to changes in work schedule and alter travel plans accordingly
  • Travel 50-75% (Domestic and International)
  • Must pass a health screening
Responsibilities
  • Manage, perform, and document all on-site installation, repair, calibration, preventative maintenance, inspection, and test tasks in a timely and detailed manner for BLI instrumentation
  • Ability to adjust coordinates, adjust spectrometer parameters, replace parts etc.
  • Diagnose alarms, errors or technical/mechanical problems and implement proper solutions
  • Perform and document system validation (IQ/OQ/PQ)
  • Triage, schedule, and provide customer support by telephone, email, or customer visits
  • Cooperate and communicate effectively with customers, project teams, engineering team, sales and others
  • Prioritized and plan work activities to make the most efficient use of allotted time
  • Report and contribute recommendations for products in development
  • Document tasks performed at customer sites with Gator’s CRM
  • Log all customer visits and generate new service-related documents
  • Report quality issues to Gator’s QMS and accomplish tasks in a timely manner
  • Represent Gator Bio in a constructive way to continue or help build positive customer relationships
  • Produce timely and accurate expense reports
  • All job duties as assigned
Desired Qualifications
  • Basic wet lab skills (e.g. pipetting, making dilutions) highly desired
  • Knowledge of IQ/OQ/PQ a plus
  • Excellent interpersonal and verbal communications skills
  • Highly organized and able to work independently

Gator Bio provides instruments and reusable biosensors for biomolecular analysis using Biolayer Interferometry (BLI) technology. These tools work by detecting light interference patterns to measure how molecules like proteins and small compounds bind to one another in real time. Unlike many traditional methods, Gator Bio offers a system with reusable probes and integrated technical support to help pharmaceutical and academic researchers study reaction rates and molecular binding sites. The company's goal is to provide precise data that helps scientists accelerate the drug discovery and clinical trial process.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Palo Alto, California

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Monod Bio partnership launches AI-NovoBody biosensors in H1 2026.
  • Gator Pilot and Pivot systems accelerate biotherapeutics discovery workflows.
  • Fluidics-free BLI supports LNP characterization and vaccine R&D with <5% CV.

What critics are saying

  • Sartorius Octet erodes 60-80% market share in 12-24 months via higher throughput.
  • Monod royalties strain margins as it scales and partners with rival BLI firms.
  • Pall FortéBIO installed base blocks upgrades, locking 70-90% users in 6-18 months.

What makes Gator Bio unique

  • Gator Bio's SMAP biosensors detect molecules as small as 150 Da without SPR.
  • HIS XT Probes use AI-designed NovoBody for superior His-tagged protein analysis.
  • GeneSwift reagents enable genome titer and integrity analysis for gene therapy.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Gator Bio who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Paid Holidays

Company News

PR Newswire
Feb 18th, 2026
Gator Bio launches HIS XT Probes with AI-designed NovoBody technology for protein analysis

Gator Bio has launched HIS XT Probes featuring AI-designed NovoBody technology for His-tagged protein analysis. The probes use computationally designed binding proteins to deliver enhanced affinity, baseline stability and data quality for antibody characterisation and biologics research. The company describes these as industry-first probes designed specifically for protein analysis applications. The technology aims to improve performance standards in biologics research and antibody development workflows. Gator Bio is based in Palo Alto, California and Seattle.

Cision
Dec 3rd, 2025
Monod Bio and Gator Bio Partner to Develop Next-Generation Biosensors for Advanced Life Science Research

Monod Bio and Gator Bio partner to develop next-generation biosensors for advanced life science research. News provided by. Gator Bio Gator Bio will integrate one of Monod's AI-designed NovoBody(TM) binding proteins into its industry-leading biolayer interferometry platform. NovoBody(TM) binding proteins deliver superior performance, stability, and engineerability compared to traditional monoclonal antibodies SEATTLE and PALO ALTO, Calif., Dec. 3, 2025 /PRNewswire-PRWeb/ - Monod Bio, a leader in computational protein design, and Gator Bio, a pioneer in biolayer interferometry (BLI) technologies, today announced a partnership to integrate one of Monod's proprietary AI-designed NovoBody(TM) protein binders into Gator's biosensor platform. The collaboration combines Monod's advanced AI-based protein design technology with Gator's proven BLI platform to deliver next-generation biosensing capabilities. Under the terms of the license agreement, Monod will supply NovoBody(TM) binding proteins to Gator Bio for use in a new biosensor product offering, one of the first to incorporate an AI-designed binding molecule. Gator Bio will oversee manufacturing, sales, and marketing of the biosensor, while Monod will receive upfront, supply, and royalty payments. The product launch is anticipated in the first half of 2026. "Our collaboration with Gator Bio marks a significant milestone in the adoption of computationally designed binding proteins for biosensing applications, paving the way for broader use of NovoBody(TM) binding proteins across life science research and diagnostics," said Daniel Silva Manzano, PhD, CEO of Monod Bio. "NovoBody(TM) binding proteins are computationally designed to deliver superior stability, manufacturability, and performance compared to traditional antibodies." "At Gator Bio, we are positioned at the intersection of AI innovation and experimental validation," said Hong Tan, PhD, CEO of Gator Bio. "Our BLI instruments are a critical enabling technology for the AI protein design revolution, providing the real-time, label-free characterization that validates computationally designed molecules. By incorporating AI-designed NovoBody(TM) binding proteins into our biosensor portfolio, we are both advancing and benefiting from the AI transformation of biologics development." "This collaboration exemplifies our 'Monod Inside' business model," said Carl Walkey, PhD, VP of Business Development at Monod Bio. "By integrating NovoBody(TM) binding proteins into leading industry platforms like Gator's, we're enabling partners to rapidly bring breakthrough products to market." About Monod Bio Monod Bio is a Seattle-based biotechnology company and a spinout from the David Baker Lab at the University of Washington's Institute for Protein Design, co-founded by Daniel Silva Manzano, Alfredo Quijano-Rubio, and David Baker. The company is a leader in de novo protein design to create novel protein binders and biosensors for research use only (RUO) and in vitro diagnostic (IVD) applications. Monod Bio's proprietary AI platform enables the generation of novel proteins using in silico methods, including its NovoBody(TM) binders, to address unmet needs. Through its "Monod Inside" business model, Monod Bio partners with leading RUO and IVD organizations to bring next-generation products to market. For more information, visit http://monod.bio. About Gator Bio Gator Bio is a leading innovator in label-free biosensor technology, delivering high-performance analytical instruments for biomolecular interaction analysis. The company's biolayer interferometry (BLI) platform serves as a critical validation technology for AI-driven protein design, providing researchers with powerful tools for real-time, quantitative characterization of next-generation biologics including computationally designed proteins and antibodies. For more information, visit gatorbio.com Media Contact Sriram Kumaraswamy, Gator Bio, 1 855-208-0743, [email protected], www.gatorbio.com Nino Floro, Gator Bio, 1 6504205727, [email protected], www.gatorbio.com SOURCE Gator Bio

Yahoo Finance
May 13th, 2025
Gator Bio Unveils Novel New GeneSwift Reagents Revolutionizing Genome Titer and Genome Integrity Analysis

Gator Bio unveils novel new GeneSwift reagents revolutionizing genome titer and genome integrity analysis.

Educating America Today
Oct 16th, 2023
Gator Bio Launches Gator® Pilot and Gator® Pivot Biolayer Interferometry Systems for Biotherapeutics Discovery

Gator Bio launches Gator® Pilot and Gator® Pivot Biolayer Interferometry systems for biotherapeutics discovery.